A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Wake Forest University Health Sciences
Mayo Clinic
National Cancer Institute (NCI)
Beijing Biotech
Ohio State University Comprehensive Cancer Center
Sumitomo Pharma America, Inc.
AbbVie
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Caribou Biosciences, Inc.
Massachusetts General Hospital
University of Oklahoma
Carevive Systems, Inc.
Dartmouth-Hitchcock Medical Center
Essen Biotech
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Institute of Hematology & Blood Diseases Hospital, China
Senti Biosciences
AbbVie
City of Hope Medical Center
Brown University
Genmab
CellCentric Ltd.
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Thomas Jefferson University
Thomas Jefferson University
UNC Lineberger Comprehensive Cancer Center
Novartis
Affiliated Hospital of Qinghai University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
Rigshospitalet, Denmark
Amgen
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Biomea Fusion Inc.
Masonic Cancer Center, University of Minnesota
University of Pennsylvania
UNC Lineberger Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Thomas Jefferson University
Thomas Jefferson University